Bates White is hosting its fifth Life Sciences Symposium on May 22–23, 2017. The conference features academic presentations on current topics such as pharmaceutical pricing, innovation, and healthcare management from top scholars. The program provides an opportunity for economists and policy makers specializing in life sciences to engage in dialogue on key policy, regulatory, litigation, and industry economic matters.
Confirmed speakers and schedule to date—
Monday, May 22
9:10–9:40 a.m.
- Amanda Starc, PhD, Northwestern University
Externalities and benefit design in health insurance
9:50–10:20 a.m.
- Ernst Berndt, PhD, Massachusetts Institute of Technology
- Rena Conti, PhD, The University of Chicago
The U.S. generic prescription drug industry: An economic perspective
10:45–11:15 a.m.
- Abby Alpert, PhD, University of Pennsylvania
Supply-side drug policy in the presence of substitutes: Evidence from the introduction of abuse-deterrent opioids
11:25–11:55 a.m.
-
Chris Stomberg, Bates White
-
Scott Weishaar, Bates White
Legal obstacles to good policy?
1:20–1:50 p.m.
- Michael Dickstein, PhD, New York University
Price-setting by committee in Medicare
2:00–2:30 p.m.
- Eric Barrette, PhD, Health Care Cost Institute
Competitive bidding for durable medical equipment: How well did CMS do?
2:55–3:25 p.m.
- Tomas Philipson, PhD, University of Chicago
How does technological change affect quality-adjusted prices in health care? Systematic evidence from thousands of innovations
3:35–4:05 p.m.
- Margaret Kyle, PhD, MINES ParisTech
Are important innovations rewarded? Evidence from pharmaceutical markets
Tuesday, May 23
9:00–9:30 a.m.
- Bradley Shapiro, PhD, University of Chicago
The non-market effects of direct-to-consumer pharmaceutical advertising
9:40–10:10 a.m.
- Maria Polyakova, PhD, Stanford University
Private provision of social insurance: Drug-specific price elasticities and cost sharing in Medicare Part D
10:35–11:05 a.m.
- W David Bradford, PhD, University of Georgia
The impact of medical marijuana legalization on prescription medication use and costs in Medicare Part D
11:15–11:45 a.m.
- Ariel Stern, PhD, Harvard University
Characterizing the drug development pipeline for precision therapies
1:00–1:30 p.m.
- Kyle Myers, PhD candidate, University of Pennsylvania
Physician-industry interactions
1:40–2:10 p.m.
- Pierre Dubois, PhD, University of Toulouse
On the role of parallel trade on manufacturers’ and retailers’ profits in the pharmaceutical sector
2:20–2:50 p.m.
- Luca Maini, PhD candidate, Harvard University
Reference pricing and drug launches in the EU: A structural approach
Registration
If you are interested in attending, please email Lucinda Lanier.
